Immunovia AB (publ) (IMMVF) News Today → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free IMMVF Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisShort InterestStock AnalysisShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineImmunovia publishes prospectus relating to the rights issueprnewswire.com - March 17 at 8:48 AMImmunovia strengthens US organization to continue commercialization of its novel IMMray™ PanCan-d testfinance.yahoo.com - December 5 at 4:46 AMCenters for Medicare & Medicaid Services finalizes its payment determination and sets a rate of $897 for Immunovia's IMMray PanCan-d testfinance.yahoo.com - November 30 at 8:32 AMChief Executive Offier, Philipp Mathieu, buys Immunovia warrantsfinance.yahoo.com - November 16 at 5:21 AMImmunovia announces the financial calendar for financial year 2023finance.yahoo.com - November 12 at 3:51 AMImmunovia Publishes Interim Report Jan-Sep 2022finance.yahoo.com - November 10 at 10:33 AMImmunovia AB: Invitation to Immunovia's Q3 presentationfinanznachrichten.de - November 5 at 7:04 PMInvitation to Immunovia's Q3 presentationfinance.yahoo.com - November 3 at 1:03 PMNomination Committee appointed for the 2023 Annual General Meeting of Immunovia AB (Publ)finance.yahoo.com - October 20 at 7:53 AMImmunovia announces executive management team changes to accelerate execution of strategic prioritiesfinance.yahoo.com - October 19 at 7:33 AMImmunovia AB: Immunovia launches a strategic partnership with Proteomedix to leverage R&D efforts with increased focus on commercializationfinanznachrichten.de - October 18 at 4:30 PMImmunovia launches a strategic partnership with Proteomedix to leverage R&D efforts with increased focus on commercializationfinance.yahoo.com - October 17 at 7:32 AMAttendo International publ AB (ATTE)investing.com - September 29 at 7:41 AMCenters for Medicare & Medicaid Services issues preliminary payment rate determination for Immunovia's IMMray PanCan-d testfinance.yahoo.com - September 26 at 10:15 AMImmunovia publ AB (IMMNOV)investing.com - September 9 at 7:34 AMImmunovia AB: Immunovia Publishes Interim Report Jan-June 2022finanznachrichten.de - August 25 at 7:27 AMImmunovia Publishes Interim Report Jan-June 2022finance.yahoo.com - August 24 at 6:20 AMImmunovia to present at Gilmartin Group's Emerging Growth Company Showcasefinance.yahoo.com - August 23 at 9:36 AMInvitation to Immunovia's Q2 presentationfinance.yahoo.com - August 22 at 11:24 AMImmunovia, Inc. Issued Clinical and Public Health Laboratory License from California Dept of Public Health for IMMray™ PanCan-d testfinance.yahoo.com - August 11 at 6:23 PMImmunovia: CPT PLA Code for the IMMray™ PanCan-d test approvedfinance.yahoo.com - July 5 at 8:25 AMThe PanDIA-1 study, for early detection of pancreatic cancer in newly onset type 2 diabetics, moves into next phasefinance.yahoo.com - June 30 at 5:04 AMPanFAM-1 Results Partly Inconclusivefinance.yahoo.com - June 27 at 5:06 AMInvitation to Immunovia's Presentation of PanFAM-1 Resultsfinance.yahoo.com - June 27 at 5:06 AMImmunovia AB appoints Philipp Mathieu as permanent CEOseekingalpha.com - June 3 at 2:34 PMPhilipp Mathieu appointed CEO of Immunovia ABfinance.yahoo.com - June 2 at 7:28 AMImmunovia gets permits in Maryland, Pennsylvania for pancreatic cancer testseekingalpha.com - May 24 at 10:42 PMImmunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US statesfinance.yahoo.com - May 23 at 4:03 AMImmunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test available in 46 US statesfinance.yahoo.com - May 17 at 3:07 AMImmunovia strengthens its US team through the appointment of Natalie Carfora as Head of Market Access USfinance.yahoo.com - May 16 at 7:24 AMImmunovia GAAP EPS of -SEK 1.95, revenue of SEK 0.18Mseekingalpha.com - April 29 at 8:47 PMImmunovia AB: Immunovia Publishes Interim Report January-March 2022finanznachrichten.de - April 28 at 7:48 AMImmunovia Publishes Interim Report January-March 2022finance.yahoo.com - April 28 at 7:48 AMInvitation to Immunovia's Q1 presentationfinance.yahoo.com - April 21 at 10:04 AMCommuniqué from the Annual General Meeting in Immunovia ABfinance.yahoo.com - April 7 at 3:42 PMImmunovia appoints Jeff Borcherding, previously Chief Marketing Officer at Myriad Genetics, to lead Immunovia's US businessfinance.yahoo.com - March 28 at 3:23 AMImmunovia AB: Immunovia publishes the annual report for 2021finanznachrichten.de - March 10 at 12:51 PMImmunovia publishes the annual report for 2021finance.yahoo.com - March 10 at 12:51 PMImmunovia, Inc. Laboratory Receives Accreditation from College of American Pathologists - a major step in the nationwide US roll-out of IMMray™ PanCan-dfinance.yahoo.com - March 8 at 8:39 AMImmunovia AB: Immunovia further strengthens IP portfolio for its IMMray PanCan-d signaturefinanznachrichten.de - March 7 at 5:06 AMImmunovia further strengthens IP portfolio for its IMMray™ PanCan-d signaturefinance.yahoo.com - March 7 at 5:06 AMNotice to the Annual General Meeting of Immunovia AB (publ)finance.yahoo.com - March 4 at 4:47 PMImmunovia Publishes Full Year Report 2021finance.yahoo.com - February 17 at 11:24 AMInvitation to Immunovia's Q4 presentationfinance.yahoo.com - February 4 at 7:51 AMImmunovia postpones Annual General Meeting pending the Temporary Meetings Actfinance.yahoo.com - February 3 at 4:31 AMIMMVF Real-Time Quotesnasdaq.com - January 25 at 8:01 PMImmunovia AB: Immunovia appoints Philipp Mathieu as Acting CEOfinanznachrichten.de - January 20 at 8:07 AMIMMVF After-Hours Quotesnasdaq.com - January 16 at 11:02 PMImmunovia's CEO to step down during 2022finance.yahoo.com - November 30 at 8:41 AMImmunovia appoints new Senior Director Investor Relations and Corporate Communicationsprnewswire.com - November 26 at 4:59 AM Get Immunovia AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for IMMVF and its competitors with MarketBeat's FREE daily newsletter. Email Address BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (Ad)BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it. Discover the name and ticker of this $2 stock here >>> IMMVF Media Mentions By Week IMMVF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMMVF News Sentiment▼0.000.45▲Average Medical News Sentiment IMMVF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMMVF Articles This Week▼00▲IMMVF Articles Average Week Get Immunovia AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for IMMVF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News AKBLF News DRTSW News ARNI News ARTLW News ASCLF News AWKNF News AXIM News BRRGF News BCTXW News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IMMVF) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressThe Weight Loss Pill That Could Disrupt a $32 Billion IndustryBehind the MarketsHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovia AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
